Pathophysiology-driven use of natural products in irritable bowel syndrome: a review
Naunyn-Schmiedeberg's Archives of Pharmacology · 2026-07 · 399 (10) · 14761-14779
DOI: 10.1007/s00210-026-05337-2 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 01.05.2026. Verfasst von Fatma Abdelhakim Mohamed und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacognosy, Faculty of Pharmacy, Heliopolis University, Cairo, 11785, Egypt. Hauptthemen laut MEDLINE: Irritable Bowel Syndrome, Biological Products, Gastrointestinal Agents. Die Arbeit nennt 127 Literaturangaben.
Abstract (Originalsprache)
Irritable bowel syndrome (IBS) is a highly prevalent disorder of gut-brain interaction characterized by chronic abdominal pain associated with altered bowel habits, including constipation-predominant (IBS-C), diarrhea-predominant (IBS-D), mixed (IBS-M), and unsubtyped forms. The pathophysiology of IBS is believed to be multifactorial as it involves dysregulation of the gut-brain axis, visceral hypersensitivity, serotonergic imbalance, epithelial barrier dysfunction, immune activation, dysbiosis, bile acid alterations, in addition to psychosocial stressors. These interacting mechanisms are known to be involved in the generation of persistent symptoms as well as the widely reported clinical heterogeneity of the disease. Current management strategies include dietary modification, psychological therapies, microbiota-targeted approaches, and pharmacological agents targeting the prevalent symptom subtype. However, treatment responses remain variable, and many patients seek complementary and natural interventions to alleviate their symptoms. Emerging evidence suggests that natural products may exert therapeutic benefits through anti-inflammatory actions, modulation of serotonergic signaling, improvement of intestinal barrier integrity, microbiota regulation, and neuromodulatory effects. Clinical studies demonstrate that certain natural interventions, particularly peppermint oil, STW 5 (Iberogast), psyllium, and several selected probiotics, can provide modest but clinically meaningful symptom improvement, especially for abdominal pain. Nonetheless, heterogeneity in trial design, short durations, small sample sizes, and limited subtype stratification restrict the strength of the resulting recommendations. This review provides a comprehensive overview of IBS pathophysiology, current treatment strategies, and mechanistic and clinical evidence supporting natural products in IBS management, while highlighting critical gaps and future research priorities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacognosy, Faculty of Pharmacy, Heliopolis University, Cairo, 11785, Egypt.
- Department of Pharmacology & Toxicology Department, Faculty of Pharmacy, Heliopolis University, Cairo, Egypt.
- Clinical Research Department, Damietta Directorate for Health Affairs, Egyptian Ministry of Health and Population, Damietta, Egypt.
- Research and Development Department, Biotechnology Research Center, 23 July St., Industrial Zone, New Damietta, 34517, Egypt.
- Biochemistry Department, Faculty of Pharmacy, Cairo University, Kasr El Ainy St., Cairo, 11562, Egypt.
- Department of Pharmacognosy, Faculty of Pharmacy, Cairo University, Cairo, 11562, Egypt. riham.adel@pharma.cu.edu.eg.
Zitieren
APA
Mohamed, F. A., Hassan, M. M., Aboulmagd, Y. M., Attallah, K. A., Ghaiad, H. R., El-Shiekh, R. A., & Fahmy, M. I. (2026). Pathophysiology-driven use of natural products in irritable bowel syndrome: a review. Naunyn-Schmiedeberg's Archives of Pharmacology, 399(10), 14761-14779. https://doi.org/10.1007/s00210-026-05337-2
Vancouver
Mohamed FA, Hassan MM, Aboulmagd YM, Attallah KA, Ghaiad HR, El-Shiekh RA, et al. Pathophysiology-driven use of natural products in irritable bowel syndrome: a review. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026;399(10):14761-14779. doi:10.1007/s00210-026-05337-2
BibTeX
@article{Mohamed2026,
author = {Mohamed, Fatma Abdelhakim and Hassan, Mennat-Allah M and Aboulmagd, Yara M and Attallah, Kareem A and Ghaiad, Heba R and El-Shiekh, Riham A and Fahmy, Mohamed I},
title = {Pathophysiology-driven use of natural products in irritable bowel syndrome: a review},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2026},
volume = {399},
number = {10},
pages = {14761--14779},
doi = {10.1007/s00210-026-05337-2}
}
EUVIMED